Tiffany Wilson Ardley
- tiffany.ardley@famu.edu
- PHONE
- 850-599-3774
- OFFICE
- Dean Pharmacy & Pharmacy Scien
Fridays (Online) 9:00 AM - 12:00 Noon
Others by Appointment
PHA 3001-301 INTRO TO PHARMACEUTIC SCIENCES (Lecture) TuTh 1:30PM - 2:20PM
PHA 4430-301 PHARMACOMED CHEM I (Lecture) Mo We 2:00PM - 3:50PM
PHA 4430L PHARMACOMED CHM I LB (Laboratory) Tu 11:00AM - 1:00PM
PHA 4931-001PROFESSIONAL SEMINAR (Lecture) We 4:00PM - 4:55PM
PHA 6433-301 PHARMACOMED CHEM I (Lecture) Mo 12:00PM - 1:40PM
Dr. Tiffany Wilson Ardley attended FAMU on a Presidential Scholarship and earned a BS in Biology and an MS in Medicinal Chemistry. In May of 2003, she made history as the first African American and first woman to earn the Ph.D. in Medicinal Chemistry from FAMU. After a Post Doctoral Fellowship at Howard University and teaching at Albany State University, she returned to FAMU where she teaches various courses in CoPPS, IPH. She served as a Faculty Senator and held the positions of Senate Secretary and Vice President. In 2017 she led the implementation of the BSPS degree program where she is the current Director. This degree is the only one in the state of Florida and the first at an HBCU with a College of Pharmacy. In 2022 she was named the Director of the Office of Undergraduate Research. She is the Principal Investigator for four US Department of Education grants and also leads a cancer drug discovery research laboratory. She has published 20 manuscripts and her research has been presented at over 50 national and international meetings. In 2020 she received a U.S. Patent for an active anti-cancer agent discovered in her research laboratory. In the community she serves as a member of the Board of Directors for PACE for Girls, Inc., and the Tallahassee Trainers Foundation Board. She is a 33 year member of Delta Sigma Theta Sorority, Inc., and has served as the Primary Advisor for the Beta Alpha Chapter at FAMU since 2018.
- Travel
- Coloring
- Making jewelry
- B.S. in Biology
Florida A&M University*1993 - M.S. in Medicinal Chemistry
Florida A&M University*1998 - Ph.D. in Medicinal Chemistry
Florida A&M University* 2003
- Associate Professor of Medicinal Chemistry (8/21 – present)
Florida A&M University, Tallahassee, FL
College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health - Assistant Professor of Medicinal Chemistry (7/08 – 7/21)
Florida A&M University, Tallahassee, FL
College of Pharmacy & Pharmaceutical Sciences - Director, Office of Undergraduate Research (5/22 – present)
Florida A&M University, Tallahassee, FL
University Academic Affairs, Office of the Provost - Director, Bachelor of Science in Pharmaceutical Sciences Degree Program (8/22 - present)
Florida A&M University, Tallahassee, FL
College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health - Coordinator, Bachelor of Science in Pharmaceutical Sciences Degree Program (8/19 –
7/22)
Florida A&M University, Tallahassee, FL
College of Pharmacy & Pharmaceutical Sciences - Assistant Director for Undergraduate Studies (7/17 – 8/19)
Florida A&M University, Tallahassee, FL
College of Pharmacy & Pharmaceutical Sciences - Director of Graduate Studies and Research (8/16 – 6/17)
Florida A&M University, Tallahassee, FL
College of Pharmacy & Pharmaceutical Sciences - Adjunct Professor of Chemistry (8/05-7/21)
Tallahassee Community College, Tallahassee, FL
Department of Science and Math - Assistant Professor of Chemistry (8/05-6/08)
Albany State University, Albany, GA
Department of Natural Sciences - Post Doctoral Research Associate (8/03-5/05)
Howard University, Washington, DC
College of Pharmacy Nursing & Allied Health Sciences
Department of Pharmaceutical Sciences - Research Associate (8/93-8/03)
Florida A&M University, Tallahassee, FL
College of Pharmacy & Pharmaceutical Sciences
- Shasline Gedeon, Aisha Montgomery, Madhavi Gangapuram, Kinfe K. Redda, Tiffany W.
Ardley. The Chemistry and Pharmacology of Tetrahydropyridines: Part 2, J. Clinical
Medical Reviews and Reports, 2023; 4(5) DOI: 10.31579/2690-8794/135.
- Henderson ED, Gangapuram M, Eyunni SV, Redda KK, Wilson-Ardley T. Design, Synthesis
and Evaluation of Novel N-Substituted-[Benzoylamino]-5-Ethyl1,2,3,6-Tetrahydropyridines
as Potential Anti-Cancer Agents. Madridge J Pharm Res. 2019; 3(1): 52-59. doi: 10.18689/mjpr-1000109
- Clark II, C.J., Ardley, T.W., and Black, J.T. “The Program of Excellence in STEM:
Involvement of Traditionally Underrepresented Students in STEM Education Through Research
and Mentoring at Florida A&M University”, Proceedings 5th IEEE Integrated STEM Conference,
Princeton University; Princeton, NJ; March 7, 2015; pp. 164-168.
- Yasmeen M. Nkrumah-Elie, Alicia M. Hudson, Equar Taka, Ramesh Badisa, David Bauer,
Shanalee S. Gallimore, Bridg’ette Israel, Tiffany Ardley, Ebenezer Oriaku, Ronald
D. Thomas*, Selina F. Darling-Reed; The attenuation of benzo(a)pyrene-induced carcinogenic
insults by diallyl disulfide (DADS) in MCF-10A cells. Nutrition and Cancer: An International
Journal, 64(7); 1112-21(2012)
- Yasmeen M. Nkrumah-Elie, Alicia M. Hudson, Equar Taka, Ramesh Badisa, Ketia Eugene,
Tiffany Ardley, Bridg’ette Israel, Sakeenah Y. Sadrud-Din, Ebenezer Oriaku, Selina
F. Darling-Reed: Diallyl trisulfide as an Inhibitor of benzo(a)pyrene-induced Precancerous
Carcinogenesis in MCF-10A cells. Food and Chemical Toxicology. 50(7);2524-30 July
(2012)
- Mohammad A. Ghafari, Tiffany W. Ardley, Madhavi Gangapuram and Kinfe K. Redda. The
synthesis of n-Substituted Carbonylamino-1,2,3,6-Tetrahydropyridines as Potential
Anti-inflammatory Agents. Synthetic Communications 41:17, 2615-2623, June 29 (2011).
To link to this article: http://dx.doi.org/10.1080/00397911.2010.515335.
- Bereket Mochona, Laine Le, Madhavi Gangapuram, Nelly Mateeva, Tiffany W. Ardley and
Kinfe K. Redda. Synthesis of 2-(N-Benzylpyrrolyl)-benzimidazoles as Potential Anti-inflammatory
Agents. Journal of Heterocyclic Chemistry 47(6): 1367-1371, November 1 (2010).
- Ivan O. Edafiogho, Samuel B. Kombian, Kettireddy V.V. Anathalaskshmi, Noha N. Salama,
Natalie D. Eddington, Tiffany L. Wilson, Mariano S. Alexander, Patrice L. Jackson,
Clive D. Hanson, K. R. Scott. Mini Review - Enaminones: Exploring Additional Therapeutic
Activities. Journal of Pharmaceutical Sciences, Oct;96(10):2509-3, (2007)DOI 10.1002/jps.20967.
- Alan J. Anderson, Jesse M. Nicholson, Oladapo Bakare, Ray J. Butcher, Tiffany L. Wilson
and K. R. Scott. Enaminones 9. Further Studies on the Anticonvulsant Activity and
Potential Type IV Phosphodiesterase Inhibitory Activity of Substituted Vinylic Benzamides.
Bioorg. Med. Chem., 14(4), 997-1006 (2006).
- Tiffany L. Wilson, Patrice L. Jackson, Clive D. Hanson, Z. Xue, Natalie D. Eddington
and Kenneth R. Scott. QSAR of The Anticonvulsant Enaminones; Molecular Modeling Aspects
and Other Assessments. Medicinal Chemistry, 1(4), 371-381 (2005).
- Noah Nabil Salama, Natalie D. Eddington, Debra Payne, Tiffany L. Wilson and K.R. Scott.
“ Multidrug Resistance and Anticonvulsants: New Studies with Some Enaminones.” Curr.
Med. Chem., 11(15), 2093-2103 (2004).
- T. Wilson and K. Redda, "Synthesis and Anti-inflammatory Activity Determinations
of Some N-[Substituted Benzoyl(phenylsulfonyl)amino] -5-Ethyl-1,2,3,6-tetrahydropyridines",
Med. Chem. Res.,12 (2), 69-86 (2003).
- Mochona, B., Wilson, T. Redda, K. "Synthesis and Anti-Inflammatory Activities of
N-Benzoylamino-1,2,3,6-Tetrahydropyridine Analogs." Drugs Under Experimental and Clinical
Research, XXIX(4), 131-140 (2003).
- Okoro, CO, Wilson, TL, Redda, KK. "Conformational Analysis and Molecular Properties of N-(Substituted Phenyl-carbonylamino)-4-(1-Hydroxymethylphenyl)-1,2,3,6-Tetrahydropyridines." Curr. Med. Chem., 10(4):313-330 (2003).
US PATENTS
Use of N-(4-Iodobenzoylamino)-5-ethyl-1,2,3,6-Tetrahydropyridine as a Treatment for
Cancer. Elizabeth Henderson, Tiffany Wilson Ardley, Kinfe Redda and Madhavi Gangapuram.
US Patent #10,646,479 B2 Issued May 12, 2020.
RESEARCH FUNDING (Active)
Minority Science and Engineering Improvement Program (PI). Funded by the United States
Department of Education. October 2023-September 2026 ($797,751) P120A230058 Funding
for Program of Excellence in STEM MAPS for the enhancement of math skills for 9th-12th
grade as well as college freshman and sophomores.
Minority Science and Engineering Improvement Program (Co-PI). Funded by the United
States Department of Education. October 2019-September 2024 ($749,217) P120A190038
Funding for Program of Excellence in STEM Enrichment for the training and mentoring
in research and recruitment of 9th-12th grades into STEM areas.
Minority Science and Engineering Improvement Program (Co-PI). Funded by the United
States Department of Education. October 2019-September 2024 (749, 512) P120A190042
Funding for Program of Excellence in STEM Environmental Education. For the training
and mentoring in research and recruitment of 9th-12th graders into the STEM area of
Environmental Science.
Minority Science and Engineering Improvement Program (Co-PI). Funded by the United
Stated Department of Education. October 2019-September 2024 ($749,333) P120A190064
Funding for the Program of Excellence in STEM Environmental Research. For the training
and mentor in research of undergraduate and graduate students in the STEM area of
Environmental Science.
RESEARCH FUNDING (Completed)
Minority Science and Engineering Improvement Program (Co-PI). Funded by the United
States Department of Education. October 2016-September 2019 ($721,710) Funding for
Program of Excellence in STEM Development for the training and mentoring in research
and recruitment of 9th-12th graders into STEM areas.
Minority Science and Engineering Improvement Program (Co-PI). Funded by the United
States Department of Education. October 2013-December 2016. ($739,240) Funding for
Program of Excellence in STEM for high school students and college freshman.
Design and Synthesis of Novel Tetrahydropyridines as Anti-Cancer Agents. Funded by
the RCMI BRIDGES Program, August 20, 2012-May 31, 2013. ($20,000)
Faculty Research Development Program Award – Florida A & M University, November 1,
2010-June 30, 2011 ($10,000) Project title “Synthesis and Biological Evaluation of
2-Pyridones as Potential Agents for the Treatment of Breast Cancer and/or Uterine
Fibroids.”
Faculty Research Assistance Program – Florida A & M University, August 1, 2010-December
31, 2010. ($4,250) Project title “Pharmacological Activity Determinations of Novel
Tetrahydropyridine Derivatives as Potential Prostate Cancer Agents.”
Faculty Research Development Program Award – Florida A & M University, November 1,
2009-March 31, 2010 ($10,000) Project title “Synthesis of 2-Pyridones as Potential
Agents for the Treatment of Breast Cancer and/or Uterine Fibroids.”
Faculty Research Development Program Award – Florida A & M University, November 1,
2008 – May 31, 2009 ($10,500) Project title “Synthesis of Pyridinesulfonicacid Amides
as Potential Breast Cancer Agents.”
Faculty Development Research Award - Albany State University, January-December 2006,
($10,000) Project title “Synthesis of Tetrahydropyridine Derivatives as Potential
Breast Cancer Agents.”
- PHA 3010 Pharmaceutical Sciences II
- PHA 3010L Pharmaceutical Sciences II Laboratory
- PHA 3050 Introduction to Pharmaceutical Sciences
- PHA 3080 Scientific Communications
- PHA 3910L Undergraduate Research
- PHA 3933 Undergraduate Research Seminar
- PHA 3571 Introduction to Principles of Drug Action
- PHA 4019 Pharmaceutical Sciences III
- PHA 4430 Pharmacomedicinal Chemistry I
- PHA 4430L Pharmacomedicinal Chemistry I Laboratory
- PHA 4431 Pharmacomedicinal Chemistry II
- PHA 4431L Pharmacomedicinal Chemistry II Laboratory
- PHA 4572 Principles of Drug Action I
- PHA 4572L Principles of Drug Action I Laboratory
- PHA 4573 Principles of Drug Action II
- PHA 4931 Professional Seminar
- PHA 6353 Natural Product Chemistry
- PHA 6421 Advanced Medicinal Chemistry I
- PHA 6422 Advanced Medicinal Chemistry II
- PHA 6433 Graduate Pharmacomedicinal Chemistry I
- PHA 6434 Graduate Pharmacomedicinal Chemistry II
- PHA 6446 Special Topics in Medicinal Chemistry
- PHA 6916 Research Internship
- PHA 6938 Research Seminar
- PHA 7979 Advanced Research
- PHA 7980 Dissertation